Filing Details
- Accession Number:
- 0001737287-25-000040
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-18 17:28:04
- Reporting Period:
- 2025-03-14
- Filing Date:
- 2025-03-18
- Accepted Time:
- 2025-03-18 17:28:04
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1737287 | Allogene Therapeutics Inc. | ALLO | Biological Products, (No Disgnostic Substances) (2836) | 823562771 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
2057918 | Machinas Benjamin Beneski | 210 East Grand Avenue South San Francisco CA 94080 | Svp, Chief Technical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2025-03-14 | 5,488 | $1.98 | 218,507 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's electionunder its equity incentive plant to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- The price reported in Column 4 is a weighted average price. These shares were sold in one transaction at the single price point of $1.975. The reporting person undertakes toprovide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at the price set forth above.